Since Remdesivir is the SOC . Every parameter we can mention in the press release where we beat the pants off rem the better . Plus safety safety safety should be mentioned for every person that now can receive treatment vs Remdesivir or other treatments that have side effects that eliminate that person for treatment ...

PS . With mild to moderate how many % wise have poor liver or kidney numbers that would eliminate them from Remdesivir or other treatments . I assume not many .. So a great P value in s/c would be the tipping point for sure . Still hoping for m/m to show well . I’m thinking it does and we are on our way .